Toggle light / dark theme

Well, every dark cloud does have a silver lining. Out of nearly three million confirmed cases of coronavirus, 1.77 million are mild cases, and more than 807,050 people have recovered as of the time of my writing this.

I think it is fair to say that a vast majority of human beings on planet Earth have one question in their minds: When will we have an actual vaccine?

Well, I have some good news.

New research from an international team of scientists has tracked a compelling series of connections between the gut microbiome and memory. Using a novel mouse model engineered to simulate the genetic diversity of a human population, the study illustrates how genetics can influence memory via bacterial metabolites produced in the gut.

Over the past few years there has been significant research interest in the relationship between memory, cognition and the gut microbiome. While certain families of bacteria that live in our gut have been implicated in memory function, this new study set out to investigate the connection from a different angle, starting with the role genetics play in this relationship.

“To know if a microbial molecule influenced memory, we needed to understand the interaction between genetics and the microbiome,” explains co-corresponding author on the study, Antoine Snijders.

Islamic religious scientist points out a hidden existential threat, worse even than the SARS-CoV-2 virus: two-legged viruses that spread liberal democracy.


Iranian scholar Alireza Ebadi, Supreme Leader Ayatollah Ali Khamenei’s representative in the Southern Khorasan Province, said in a lecture that aired on Khorasan Jonoobi TV (Iran) on April 10, 2020 that the “virus” of Western liberal democracy is even worse than the coronavirus since it has caused the deaths and displacement of millions of people, two world wars, coups in various countries such as Iraq, the spread of cholera in Yemen, and Western intervention in Syria, Afghanistan, India, Pakistan, and elsewhere. Ebadi expressed hope that once humanity defeats the “pest” of the coronavirus, it will “make sure the greatest pests of all do not escape.” He added: “May God [save] humanity from [the] two-legged viruses.”

Cytokine storms may affect the severity of COVID-19 cases by lowering T cell counts, according to a new study published in Frontiers in Immunology. Researchers studying coronavirus cases in China found that sick patients had a significantly low number of T cells, a type of white blood cell that plays a crucial role in immune response, and that T cell counts were negatively correlated with case severity.

Interestingly, they also found a high concentration of cytokines, a protein that normally helps fight off infection. Too many cytokines can trigger an excessive inflammatory response known as a cytokine storm, which causes the proteins to attack . The study suggests that coronavirus does not attack T cells directly, but rather triggers the cytokine release, which then drives the depletion and exhaustion of T cells.

The findings offer clues on how to target treatment for COVID-19, which has become a worldwide pandemic and a widespread threat to human health in the past few months. “We should pay more attention to T cell counts and their function, rather than respiratory function of patients,” says author Dr. Yongwen Chen of Third Military Medical University in China, adding that “more urgent, may be required in patients with low T lymphocyte counts.”

A research collaboration and ensuing friendship between a trauma surgeon in Oregon and a handful of engineers in Florida has resulted in a new ventilator design that requires no electricity and could be a game-changer during the COVID-19 pandemic.

Albert Chi, who specializes in critical care and prosthetics, was keeping a close eye on COVID-19 during the early days. He immediately began working with his team at Oregon Health and Science University to develop a new, easy way to replicate ventilators that could be deployed anywhere. Specializing in trauma, Chi as a retired commander of the U.S. Navy Reserve and well versed in extreme conditions.

When Chi had a design, he called his friend and clinical-trial collaborator Albert Manero CEO and co-founder of Limbitless Solutions in Orlando, Florida.